Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.
估計腎小球過濾率、白蛋白尿和不良結果:個別參與者資料的荟萃分析。
JAMA 2024-04-04
Shifts in KDIGO CKD risk groups with empagliflozin: Kidney-protection from SGLT2 inhibition across the spectrum of risk.
empagliflozin 對 KDIGO CKD 風險組的變化:SGLT2 抑制劑在風險範疇中對腎臟的保護。
J Diabetes Complications 2023-12-15
Cardiovascular risk due to diabetes mellitus in patients with chronic kidney disease-prospective data from the German Chronic Kidney Disease cohort.
糖尿病對慢性腎臟病患者心血管風險的影響-德國慢性腎臟病群的前瞻性數據。
Clin Kidney J 2023-11-03
Haemoglobin trajectories in chronic kidney disease and risk of major adverse cardiovascular events.
慢性腎臟病中的血紅蛋白軌跡及主要不良心血管事件風險。
Nephrol Dial Transplant 2024-03-28
Cardiovascular and renal outcomes with varying degrees of kidney disease in high-risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE-O trial.
高風險第2型糖尿病患者不同程度腎病變的心血管和腎臟結果:AMPLITUDE-O 試驗數據的流行病學分析。
Diabetes Obes Metab 2024-03-05
Associations of metabolic variabilities and cardiovascular outcomes according to estimated glomerular filtration rate in chronic kidney disease: a nationwide observational cohort study.
慢性腎臟病患者中代謝變異性與心血管結果的相關性:根據估計腎小球過濾率的全國觀察性群體研究。
Kidney Res Clin Pract 2024-01-11
Mortality, Health Care Burden, and Treatment of CKD: A Multinational, Observational Study (OPTIMISE-CKD).
CKD的死亡率、醫療負擔和治療:一項跨國觀察性研究(OPTIMISE-CKD)。
Kidney360 2024-04-10
Five-year Trajectory about Screening for Complication of Diabetes Kidney Disease and Cardiovascular Disease Mortality : Focusing on Regional Difference.
五年來有關糖尿病腎病變和心血管疾病死亡的檢測軌跡:著重於區域差異。
Kidney Blood Press Res 2024-03-07
Significance of eGFR and proteinuria for cardiovascular disease in individuals beyond 85 years.
85歲以上個體中eGFR和蛋白尿對心血管疾病的重要性。
Nephrol Dial Transplant 2024-06-10
Acute myocardial infarction and chronic kidney disease: A nationwide cohort study on management and outcomes from 2010-2022.
急性心肌梗塞與慢性腎病:2010-2022年的全國性隊列研究管理與結果。
Clin J Am Soc Nephrol 2024-07-18